| 1 |
Yu Z, Tao C, Xiao A, et al. Chinese multidisciplinary guideline for management of hypertensive intracerebral hemorrhage [J]. Chin Med J (Engl), 2022, 135(19): 2269-2271.
|
| 2 |
Collaborators GBDS. Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019 [J]. Lancet Neurol, 2021, 20(10): 795-820.
|
| 3 |
Tu WJ, Wang LD. China stroke surveillance report 2021 [J]. Mil Med Res, 2023, 10(1): 33.
|
| 4 |
Wang YJ, Li ZX, Gu HQ, et al. China Stroke Statistics: an update on the 2019 report from the National Center for Healthcare Quality Management in Neurological Diseases, China National Clinical Research Center for Neurological Diseases, the Chinese Stroke Association, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention and Institute for Global Neuroscience and Stroke Collaborations [J]. Stroke Vasc Neurol, 2022, 7(5): 415-450.
|
| 5 |
吴燕, 李淮玉, 李虎. 1298例自发性脑出血流行病学与临床特点分析 [J]. 中国循证医学杂志, 2010, 10(11): 1256-1258.
|
| 6 |
Wang D, Wang J, Li Z, et al. C-reaction protein and the severity of intracerebral hemorrhage: a study from Chinese stroke center alliance [J]. Neurol Res, 2022, 44(4): 285-290.
|
| 7 |
韩大东, 吴小芳, 吴跃刚. 急性脑出血患者C反应蛋白水平与预后的关系 [J]. 中国医药科学, 2020, 10(3): 261-264.
|
| 8 |
中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组. 中国脑出血诊治指南(2019) [J]. 中华神经科杂志, 2019, 52(12): 994-1005.
|
| 9 |
林莹, 张宇清. 高原性高血压的患病率、发病机制治疗研究进展 [J]. 中华高血压杂志, 2020, 28(1): 82-86.
|
| 10 |
苑斌, 何士华, 桑艳芳, 等. 西藏高原地区与山东菏泽平原地区脑出血临床特点的比较 [J]. 中华老年心脑血管病杂志, 2019, 21(7): 729-732.
|
| 11 |
徐子寓, 童刚, 王琼, 等. 手术治疗高原性高血压性脑出血影响预后因素分析 [J]. 西藏科技, 2021(5): 63-66.
|
| 12 |
贺中正, 马健康, 贡桑, 等. 海拔4000米以上超高原地区幕上高血压脑出血特点分析 [J/OL]. 中华脑血管病杂志(电子版), 2020, 14(2): 96-99.
|
| 13 |
耿卫峰, 何小娜, 吴勤奋. 急性期脑出血患者血清炎症因子、超敏C反应蛋白水平的变化及临床意义 [J]. 新疆医科大学学报, 2018, 41(5): 565-568.
|
| 14 |
赵秀丽, 王兰桂, 杨春丽, 等. 不同海拔缺血性脑血管病患者血浆hs-CRP、FIB和血WBC变化与脑损害关系 [J]. 青海医学院学报, 2014, 35(3): 172-177.
|
| 15 |
欧阳桂兰, 朱海兵, 赖燕蔚, 等. N-端脑钠肽前体和超敏C反应蛋白在幕上脑出血联合检测的临床意义 [J]. 赣南医学院学报, 2019, 39(1): 11-13, 29.
|
| 16 |
Sagar R, Kumar A, Verma V, et al. Incremental accuracy of blood biomarkers for predicting clinical outcomes after intracerebral hemorrhage [J]. J Stroke Cerebrovasc Dis, 2021, 30(3): 105537.
|
| 17 |
Bernstein JE, Browne JD, Savla P, et al. Inflammatory markers in severity of intracerebral hemorrhage Ⅱ: a follow up study [J]. Cureus, 2021, 13(1): e12605.
|
| 18 |
Bernstein JE, Savla P, Dong F, et al. Inflammatory markers and severity of intracerebral hemorrhage [J]. Cureus, 2018, 10(10): e3529.
|